ROCKWELL MEDICAL, INC. Payments to Acquire Debt Securities, Available-for-sale
ROCKWELL MEDICAL, INC. (RMTI) reported Payments to Acquire Debt Securities, Available-for-sale of $14.14 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt · last filed 2026-08-13
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-06-30 was $7.07M, a 140.56% increase year-over-year.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2026-03-31 was $7.07M, a 140.71% increase year-over-year.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-12-31 was $11.24M.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for the quarter ending 2025-09-30 was $7.08M, a 19.57% increase year-over-year.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for fiscal 2025 was $24.20M, a 313.14% increase from fiscal 2024.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for fiscal 2024 was $5.86M, a 2.75% increase from fiscal 2023.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for fiscal 2023 was $5.70M, a 73.23% decline from fiscal 2022.
- ROCKWELL MEDICAL, INC. payments to acquire debt securities, available-for-sale for fiscal 2022 was $21.30M, a 18.27% decline from fiscal 2021.
| Period end | Payments to Acquire Debt Securities, Available-for-sale 3 month | Payments to Acquire Debt Securities, Available-for-sale 3 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 6 month | Payments to Acquire Debt Securities, Available-for-sale 6 month as first filed | Payments to Acquire Debt Securities, Available-for-sale 9 month | Payments to Acquire Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $14.14M 10-Q · filed 2026-08-13 | $25.39M derived: sum of 3 quarters · filed 2026-08-13 | $32.47M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $7.07M 10-Q · filed 2026-05-07 | $18.32M derived: sum of 2 quarters · filed 2026-05-07 | $25.40M derived: sum of 3 quarters · filed 2026-05-07 | $28.34M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $11.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $18.32M derived: sum of 2 quarters · filed 2026-03-26 | $21.26M derived: sum of 3 quarters · filed 2026-08-13 | $24.20M 10-K · filed 2026-03-26 | ||
| 2025-09-30 | $7.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $10.02M derived: sum of 2 quarters · filed 2026-08-13 | $12.96M 10-Q · filed 2025-11-12 | $12.89M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | $2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $5.88M 10-Q · filed 2026-08-13 | $5.81M derived: sum of 3 quarters · filed 2026-08-13 | $11.73M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | $2.94M 10-Q · filed 2026-05-07 | $2.88M derived: sum of 2 quarters · filed 2026-05-07 | $8.80M derived: sum of 3 quarters · filed 2026-05-07 | $8.80M derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | -$63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $5.86M derived: sum of 2 quarters · filed 2026-03-26 | $5.86M derived: sum of 3 quarters · filed 2026-03-26 | $5.86M 10-K · filed 2026-03-26 | ||
| 2024-09-30 | $5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $5.92M derived: sum of 2 quarters · filed 2025-11-12 | $5.92M 10-Q · filed 2025-11-12 | $7.87M derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $0.00 10-Q · filed 2025-08-14 | $1.95M derived: sum of 3 quarters · filed 2025-08-14 | $1.87M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | $1.95M derived: sum of 2 quarters · filed 2025-05-12 | $1.87M derived: sum of 3 quarters · filed 2025-05-12 | $3.65M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $1.95M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $1.87M derived: sum of 2 quarters · filed 2025-03-20 | $3.65M derived: sum of 3 quarters · filed 2025-03-20 | $5.70M 10-K · filed 2025-03-20 | ||
| 2023-09-30 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $1.70M derived: sum of 2 quarters · filed 2024-11-12 | $3.75M 10-Q · filed 2024-11-12 | $7.66M derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $3.83M 10-Q · filed 2024-08-08 | $7.74M derived: sum of 3 quarters · filed 2024-08-08 | $22.32M derived: sum of 4 quarters · filed 2024-08-08 | ||
| 2023-03-31 | $2.05M 10-Q · filed 2024-05-14 | $5.96M derived: sum of 2 quarters · filed 2024-05-14 | $20.54M derived: sum of 3 quarters · filed 2024-05-14 | $20.54M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $3.91M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $18.49M derived: sum of 2 quarters · filed 2024-03-21 | $18.49M derived: sum of 3 quarters · filed 2024-03-21 | $21.30M 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $14.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $14.58M derived: sum of 2 quarters · filed 2023-11-14 | $17.39M 10-Q · filed 2023-11-14 | $24.34M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $2.81M 10-Q · filed 2023-08-14 | $9.76M derived: sum of 3 quarters · filed 2023-08-14 | $15.10M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $2.81M 10-Q · filed 2023-05-15 | $9.76M derived: sum of 2 quarters · filed 2023-05-15 | $15.10M derived: sum of 3 quarters · filed 2023-05-15 | $21.66M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $6.95M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $12.29M derived: sum of 2 quarters · filed 2023-03-30 | $18.85M derived: sum of 3 quarters · filed 2023-03-30 | $26.06M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $5.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $11.89M derived: sum of 2 quarters · filed 2022-11-14 | $19.11M 10-Q · filed 2022-11-14 | $24.88M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $6.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $13.77M 10-Q · filed 2022-08-15 | $19.54M derived: sum of 3 quarters · filed 2022-08-15 | $26.56M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $7.21M 10-Q · filed 2022-05-16 | $12.99M derived: sum of 2 quarters · filed 2022-05-16 | $20.00M derived: sum of 3 quarters · filed 2022-05-16 | $27.65M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $5.78M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | $12.79M derived: sum of 2 quarters · filed 2022-04-08 | $20.43M derived: sum of 3 quarters · filed 2022-04-08 | $29.31M 10-K · filed 2022-04-08 | ||
| 2020-09-30 | $7.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $14.66M derived: sum of 2 quarters · filed 2021-11-15 | $23.53M 10-Q · filed 2021-11-15 | $31.01M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $7.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $16.51M 10-Q · filed 2021-08-16 | $16.51M 10-Q · filed 2020-08-10 | $23.99M derived: sum of 3 quarters · filed 2021-08-16 | $36.42M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $8.87M 10-Q · filed 2021-05-17 | $8.87M 10-Q · filed 2020-05-11 | $16.35M derived: sum of 2 quarters · filed 2021-05-17 | $28.78M derived: sum of 3 quarters · filed 2021-05-17 | $41.74M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $7.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $19.90M derived: sum of 2 quarters · filed 2021-03-31 | $32.87M derived: sum of 3 quarters · filed 2021-03-31 | $41.68M 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $12.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $25.39M derived: sum of 2 quarters · filed 2020-11-09 | $34.20M 10-Q · filed 2020-11-09 | |||
| 2019-06-30 | $12.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $21.77M 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $8.81M 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |